This company analysis examines Almirall's market position and future outlook. The profile encompasses global company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with forecasts for key drugs to 2010.
This company analysis examines Almirall's market position and future outlook. The profile encompasses global company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to read this report
Benchmark Almirall's performance against key players in the ethical pharmaceuticals market
Assess Almirall's strategic options in the face of the increasing presence and experience of large pharmaceutical companies within the Spanish market
Understand the drivers of Almirall's forecast decline in sales to 2010
This company analysis examines Almirall's market position and future outlook. The profile encompasses global company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with forecasts for key drugs to 2010.